BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9173422)

  • 1. [Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance].
    Ukena D; Koper I; Braun H; Leutz M; Schlimmer P; Sybrecht GW
    Pneumologie; 1997 Mar; 51(3):317-23. PubMed ID: 9173422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
    Martin RJ; Kraft M; Beaucher WN; Kiechel F; Sublett JL; LaVallee N; Shilstone J
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):121-6. PubMed ID: 10480584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily].
    Ringbaek TJ; Søes-Petersen U; Christensen M; Iversen ET; Rasmussen FV
    Ugeskr Laeger; 1996 Jul; 158(27):3940-3. PubMed ID: 8701511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of salmeterol in nocturnal asthma: a comparative study with theophylline-ketotifen association. A French multicenter group].
    Muir JF; Georges D
    Rev Mal Respir; 1992; 9 Suppl 1():R23-6. PubMed ID: 1350366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
    Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled salmeterol or oral theophylline in nocturnal asthma?
    Selby C; Engleman HM; Fitzpatrick MF; Sime PM; Mackay TW; Douglas NJ
    Am J Respir Crit Care Med; 1997 Jan; 155(1):104-8. PubMed ID: 9001297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
    Hordvik NL; Sammut PH; Judy CG; Colombo JL
    Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients.
    Adachi M; Aizawa H; Ishihara K; Ohta K; Sano Y; Taniguchi H; Nakashima M
    Respir Med; 2008 Jul; 102(7):1055-64. PubMed ID: 18394875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
    Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
    Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhaled salmeterol or oral theophylline in nocturnal asthma?].
    Ukena D
    Pneumologie; 1997 Sep; 51(9):919-20. PubMed ID: 9411444
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicentre trial. French Multicentre Study Group.
    Muir JF; Bertin L; Georges D
    Eur Respir J; 1992 Nov; 5(10):1197-200. PubMed ID: 1486965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral fenoterol versus sustained release theophylline in adult asthmatics.
    Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline.
    Inoue H; Komori M; Matsumoto T; Fukuyama S; Matsumura M; Nakano T; Tsuda M; Matsumoto K; Kanaya A; Moriwaki A; Aizawa H; Yoshida M; Nakanishi Y
    Respiration; 2007; 74(6):611-6. PubMed ID: 16960440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group.
    Paggiaro PL; Giannini D; Di Franco A; Testi R
    Eur Respir J; 1996 Aug; 9(8):1689-95. PubMed ID: 8866596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
    Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; Pétavy F; James M
    Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
    Fardon T; Haggart K; Lee DK; Lipworth BJ
    Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sustained-release theophylline in nocturnal asthma.
    Freeman W; Packe GE; Cayton RM
    Br J Clin Pract; 1991; 45(1):21-5. PubMed ID: 1931534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.